Moneycontrol PRO

business

JHS Svendgaard expect to clock 20-30% revenue growth in FY18

In an interview to CNBC-TV18, Nikhil Nanda, MD of JHS Svendgaard Laboratories gave his outlook for the year.

first published: Jun 8, 2017 03:52 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347